Anish Suri

Anish Suri

Company: Cue Biopharma

Job title: Chief Scientific Officer


A Novel Biologics Platform for Antigen-Specific Immunotherapy 3:15 pm

• Insight behind how the ImmunoSTAT platform incorporates pHLA and relevant immune-modulatory signals to directly engage T cells in a patient’s body • Incorporating different HLA alleles, T cell epitopes and secondary signals, which allows for targeting different diseases and patient subsets • Case study evidence to support selective and specific biological effects on antigen-specific…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.